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Skin-resident dendritic cells (DCs) likely encounter incoming viruses in the first place, and their 
migration to lymph nodes following virus capture may promote viral replication. However, the 
molecular mechanisms underlying these processes remain unclear. In the present study, We found that 
compared to cell-free viruses, DC-bound viruses showed enhanced capture of JEV by T cells. 
Additionally, JEV infection was increased by co-culturing DCs and T cells. Blocking the C-type lectin 
receptor DC-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) with 
neutralizing antibodies or antagonists blocked JEV transmission to T cells. Live-cell imaging revealed 
that DCs captured and transferred JEV viral particles to T cells via virological synapses formed at DC–
T cell junctions. These findings indicate that DC-SIGN plays an important role in JEV transmission 
from DCs to T cells and provide insight into how JEV exploits the migratory and antigen-presenting 
capabilities of DCs to gain access to lymph nodes for dissemination and persistence in the host. 
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INTRODUCTION 
Japanese encephalitis virus (JEV) is a member of the Flavivirus genus and spreads via mosquitoes  (van 
den Hurk A F, et al., 2009). As the major cause of viral encephalitis among children in Asia, JEV 
infection can lead to permanent neurological sequelae or even death due to the lack of a specific 
treatment  (Iwasaki Y, et al., 1986). JEV can replicate in different types of primary cell and in 
immortalized cell lines from a variety of species (Pierson T C, et al., 2013). The permissiveness of T 
lymphocytes to JEV is well documented. For instance, a previous study showed that a small fraction of 
T lymphocytes and macrophages in mice was targeted during acute JEV infection (Aleyas A G, et al., 
2009). JEV can establish a latent infection in T lymphocytes of the spleen in mice that can be reactivated 
during pregnancy or by cyclophosphamide treatment  (Mathur A, et al., 1989; Mathur A, et al., 1986). 
Clinical studies have shown that three out of 40 children with acute JE developed recurrence of the 
disease 8–9 months later due to virus recovered from T lymphocytes; in fact, JEV was also isolated 
from the T lymphocytes of asymptomatic children (Sharma S, et al., 1991). The virus likely requires 
early-stage dissemination from sites of infection in the skin to secondary lymphoid organs. However, it 
is unclear how JEV infects T lymphocytes. 
Dendritic cells (DCs) are professional antigen-presenting cells that act as a bridge between 
peripheral mucosal and lymphoid tissues (Malissen B, et al., 2014). It has been reported that 
flaviviruses-infected DCs migrate to draining lymph nodes where efficient viral replication takes place, 
leading to viral entry into the circulation and internal organs (Diamond M S, et al., 2003; Pierson T C, 
et al., 2013). We speculate that the antigen-presenting and migratory capabilities of DCs are exploited 
by JEV for transfer of the virus to T cells in a mechanism similar to that used by human 
immunodeficiency virus (HIV)-1, in which DCs capture viruses and promote trans-infection of target 
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cells expressing CD4 and a co-receptor (Geijtenbeek T B, et al., 2000). 
Immature DCs cultured from monocytes in the presence of granulocyte-macrophage colony-stimulating 
factor (GM-CSF) and interleukin (IL)-4 express high levels of DC-specific intercellular adhesion 
molecule-3-grabbing non-integrin (DC-SIGN), which meditates DC interactions with T lymphocytes 
through recognition of intercellular cell adhesion molecule (ICAM)-3 (Geijtenbeek T B, et al., 2000; 
Shimauchi T, et al., 2015). DC-SIGN is thought to play an important role in mediating trans infection 
of T cells by several viruses, including HIV-1, cytomegalovirus, enterovirus 71, and measles virus  (de 
Witte L, et al., 2008; Geijtenbeek T B, et al., 2000; Halary F, et al., 2002; Ren X X, et al., 2014). We 
previously reported that DC-SIGN can efficiently capture and concentrate viral particles at the cell 
surface and thus facilitate cis infection of JEV (Wang P, et al., 2016), but its role in promoting trans-
infection of T cells is not known. This was investigated in the present study using DCs-T cells co-
culture system and live-cell spinning-disk confocal microscopy. Our results demonstrate that DC-SIGN 




MATERIALS AND METHODS 
Cells and viruses 
C6/36 cells (provided by Professor Hanzhong Wang, Wuhan Institute of Virology, CAS) were grown in 
Eagle’s minimal essential medium (ATCC, Manassas, VA, USA) supplemented with 10% fetal bovine 
serum (FBS) at 28 °C and 5% CO2. Baby hamster kidney cells (BHK-21) were grown in Dulbecco’s 
modified Eagle’s medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% FBS (Invitrogen), 
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100 U/ml penicillin-streptomycin, and 2 mM L-glutamine at 37 °C and 5% CO2. 
Primary DCs and T cells were obtained as previously described  (Jin W, et al., 2014; Li C, et 
al., 2014). Briefly, human peripheral blood mononuclear cells (PBMCs) were isolated from blood 
samples collected from healthy adult volunteers by the standard Ficoll-Paque method. To obtain 
immature DCs, monocytes were isolated from PBMCs by negative selection using the Myeloid 
Dendritic Cell Isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Purified monocytes were 
then differentiated into immature DCs in the presence of IL-4 (500 U/ml) and GM-CSF (800 U/ml). 
The cells were harvested on day 6 and analyzed by fluorescence-activated cell sorting (FACS) on a 
FACSAriaIII flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) and used in subsequent assays. 
To prepare T cells, isolated PBMCs were activated with phytohemagglutinin (PHA, 1 µg/ml; Sigma-
Aldrich, St. Louis, MO, USA) and cultured in complete Roswell Park Memorial Institute (RPMI)-1640 
medium. On day 3, the cells were washed and cultured with IL-2 (100 U/ml). PHA-activated PBMCs 
were harvested on day 6 as T cells.JEV strain SA14-14 was propagated in C6/36 cells and titered in 
BHK-21 cells. Viruses were concentrated and purified by ultracentrifugation. Briefly, 25 ml of virus-
containing medium (cleared by centrifugation and filtration) was overlaid on 5 ml of 25% sucrose in 
conical tubes and centrifuged at 25,000 rpm for 2 h at 4 °C in an SW28 swinging bucket rotor (Beckman 
Coulter, Brea, CA, USA). The resultant pellet was dissolved in 100 μl/tube phosphate-buffered saline 
(PBS) without calcium or magnesium (Invitrogen) for 2 h at 4 °C. Aliquots were stored at −80 °C or 
were immediately purified by overlaying the concentrated virus on a continuous sucrose gradient (20%–
55% w/w in PBS) and centrifuging at 35,000 rpm for 2 h at 4 °C in an SW55 swinging bucket rotor 
(Beckman Coulter). 
JEV was labeled with Alexa Fluor® 488 Carboxylic Acid (Invitrogen) in HEPES (20 mmol/L) 
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according to the manufacturer’s instructions. Labeled JEV was designated as JEV-AF488. Free dye was 
removed by passage through a gel filtration column and the virus was banded on a sucrose gradient as 
described above. Labeling was verified by SDS-PAGE, and infectivity was monitored with the plaque 
formation assay. Labeled JEV was exposed to ultraviolet light before use for live-cell confocal 
microscopy. 
 
Antibodies and reagents 
Mouse anti-DC-SIGN neutralizing monoclonal antibody (mAb; mAb161) and corresponding isotype 
control antibodies were purchased from R&D Systems (Minneapolis, MN, USA). Mouse anti-β-actin 
and horseradish peroxidase (HRP)-conjugated goat-anti-mouse antibodies were purchased from Santa 
Cruz Biotechnology (Santa Cruz, CA, USA). Mouse polyclonal antibody against domain III of JEV E 
glycoprotein was generated by immunizing BALB/c mice (BHK Ltd., Beijing, China) with JEV E DIII 
protein (a gift from Professor Gengfu Xiao, Wuhan Institute of Virology, CAS). Briefly, mice were 
subcutaneously injected with 200 μg of JEV E DIII protein in Freund’s complete adjuvant, followed by 
two boost immunizations with the same amount of antigen in Freund’s incomplete adjuvant at 3-week 
intervals. Two weeks after the final immunization, blood samples were collected and sera were pooled 
and purified with protein A/G (Invitrogen). EDTA and mannan were purchased from Sigma-Aldrich. 
Alexa Fluor® 488 Carboxylic Acid was purchased from Invitrogen. 
 
Western blotting 
Protein extracts were separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane 
that was probed with antibodies against JEV E (1:2000) and β-actin (1: 1000, Santa Cruz 
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Biotechnology). Immunoreactivity was detected with HRP-conjugated goat anti-mouse IgG antibody 
(1: 5000; Santa Cruz Biotechnology) and enhanced chemiluminescence western blotting substrate 
(Thermo Fisher Scientific, Waltham, MA, USA). 
 
Virus binding assay 
Cells were incubated with JEV or JEV-AF488 for 1 h on ice at a multiplicity of infection (MOI) of 10 
in binding buffer composed of RPMI-1640 (pH 7.4), 0.2% FBS, 1 mmol/L CaCl2, and 2 mmol/L MgCl2. 
After washing with cold PBS containing 1% bovine serum albumin to remove unbound viruses, binding 
was quantified by FACS. DCs were seeded in poly-L-lysine-coated wells and incubated for 1 h at 37°C 
followed by incubation with JEV-AF488. For the inhibition assay, cells were pretreated with inhibitors 
for 30 min before exposure to viruses. 
 
JEV transmission in cis and in trans 
DCs (1 × 106) were pulsed with JEV-AF488 (3 × 107 PFU) in binding buffer for 1 h on ice, then washed 
three times to remove unbound viruses and incubated with T cells (3 × 106) for predetermined times. T 
cells were labeled with CellTracker Blue fluorescence dye (C2110; Invitrogen) prior to incubation with 
DCs. Viral transmission was quantified by FACS or analyzed by fluorescence microscopy. T cells (3 × 
106) pulsed with JEV-AF488 (3 × 107 PFU) served as the control. For the transmission inhibition assay, 
DCs were pretreated with inhibitor for 30 min before exposure to viruses and then incubated with T 
cells. In the non-contact co-culture system, T cells (3 × 104) were seeded in the upper chambers of an 
8-μm 24-well Transwell plate (Corning, NY, USA); the lower chamber was seeded with JEV-pulsed 
DCs (1 × 104). For the transmission inhibition assay, DCs were pretreated with inhibitors for 30 min 
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before exposure to viruses and then co-cultured with T cells. Transmission efficiency was determined 
by titration of the supernatant and by western blot analysis of viral protein E. For analysis of T cell 
trans-infection, T cells were labeled with CellTracker Blue fluorescent dye (C2110; Invitrogen) before 
mixing with JEV-AF488-pulsed DCs. Cells were co-cultured at 37°C for 3 h, fixed in 1% formaldehyde, 
and then evaluated by FACS. Data were analyzed using BD FACSDiva software (BD Biosciences). 
 
Live cell spinning-disk microscopy 
DCs were seeded in 3.5-cm diameter glass-bottomed culture dishes (MatTek, Ashland, MA, USA) pre-
coated with poly-L-lysine. After pulsing with JEV-AF488 on ice, DCs were mixed with T cells at a ratio 
of 1:3. Dishes were then transferred to a chamber in which temperature, humidity, and CO2 levels were 
controlled during imaging. Time-lapse live cell imaging was performed on an Eclipse Ti inverted 
microscope (Nikon, Tokyo, Japan) using a 60× NA 1.4 oil objective or on a spinning-disk confocal 
microscope (UltraView VoX; PerkinElmer, Waltham, MA, USA). Images were acquired with excitation 
at 488 nm in differential interference contrast mode. Image sequences were processed and analyzed 
using Volocity software (PerkinElmer, Waltham, MA, USA). 
 
Statistical analysis 
Data were analyzed with Prism v.5.00 software (GraphPad Inc., La Jolla, CA, USA). Values are reported 
as the mean ± SD of triplicate samples unless otherwise specified. Differences between groups were 




DC-SIGN increases JEV particle transfer from DCs to T cells 
To determine whether JEV exploits DCs to gain access to lymph nodes for efficient replication and 
subsequent transmission, we examined the transfer of DC-captured JEV to T cells. Monocytes were 
isolated from PBMCs and differentiated into DCs in the presence of IL-4 (500 U/mL) and GM-CSF 
(800 U/mL) (Supplementary Material S1A). Surface expression of DC-SIGN was detected by flow 
cytometry (Supplementary Material S1B). AF488 fluorescent dye labeling was used to track JEV 
particle movement in DC–T cell co-cultures. DC-SIGN-expressing cells were infected at similar rates 
by JEV-AF488 and unlabeled JEV (Supplementary Material S2), indicating that the fluorescent dye 
labeling did not compromise virus infectivity. T cells were labeled with CellTracker Blue fluorescent 
dye before pulsing with JEV-AF488 (cell-free virus) at an MOI of 10 or with DC-associated JEV-
AF488 for 30 min; JEV transmission was then quantified by flow cytometry by analyzing the 
CellTracker Blue+ JEV-AF488+ population. The binding efficacy of cell-free virus to CellTracker Blue-
labeled T cells (i.e., cis infection, in cis) was low even at an MOI of 10. When DCs were incubated with 
the same amount of virus followed by co-culturing with T cells (i.e., trans infection, in trans), the 
binding efficacy of cell-associated virus was higher than that of cell-free virus (Figure 1A, 1B). These 
results indicate that JEV can be transmitted from DCs to T cells in trans. 
The C-type lectin receptor DC-SIGN is expressed at high levels on the surface of immature 
DCs and can mediate their interactions with T lymphocytes via recognition of ICAM-3  (Figdor C G, 
et al., 2002; Geijtenbeek T B, et al., 2000). DC-SIGN plays an important role in mediating trans 
infection of T cells by several viruses  (de Witte L, et al., 2008; Geijtenbeek T B, et al., 2000; 
Geijtenbeek T B, et al., 2000; Halary F, et al., 2002; Ren X X, et al., 2014). Based on our demonstration 
that DC-SIGN is an attachment receptor for JEV and enhances DC infection in cis  (Wang P, et al., 
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2016), we speculated that it participates in DC-mediated transfer of JEV to T cells. To evaluate this 
possibility, monocyte-derived DCs were pre-treated with specific blocking antibodies against DC-SIGN 
(mAb161) or with C-type lectin inhibitors (mannan and EDTA) as described in our previous 
studies  (Wang P, et al., 2016); CellTracker Blue+ JEV-AF488+ populations were then analyzed by 
flow cytometry. The fraction of CellTracker Blue+ JEV-AF488+ cells was about 14% after co-culturing 
with JEV-pulsed DCs for 3 h, and virions transmitted to T cells were unaffected by pretreatment with 
isotype control antibodies but were inhibited by anti-DC-SIGN mAb161, EDTA, or mannan treatment 
(Figure 1C, 1D), indicating that DC-SIGN plays an important role in mediating the transmission of JEV 
from DCs to T cells in trans. 
 
DC-SIGN is required for efficient JEV infection in DC–T cell co-cultures 
Given that DC-SIGN increased the transfer of JEV particles from DCs to T cells, we investigated 
whether co-culturing DCs and T cells would increase JEV infection. To mimic in vivo conditions in 
which JEV levels are likely to be low, DCs were treated with low titers of JEV (MOI = 0.001) and then 
co-cultured with T cells for 72 h (Figure 2A-a). DCs or T cells treated with equivalent amounts of JEV 
but without co-cultivation served as controls. As expected, neither DCs nor T cells alone were infected 
by the low titers of JEV. In contrast, more viral proteins (Figure 2B) and progeny virions (Figure 2C) 
were produced in T cells co-cultured with JEV-pulsed DCs. This effect was blocked by treatment with 
DC-SIGN inhibitors (Figure 2B, 2C), indicating that enhanced JEV infection in DC–T cell co-cultures 
is DC-SIGN-dependent—that is, DC-SIGN endows DCs with the ability to capture and transfer JEV 
particles to T cells, which promotes JEV replication in the DC–T cell microenvironment. 
The contact area between a T cell and a DC is known as the immunological synapse  (Norcross 
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M A, 1984; Paul W E, et al., 1987; Shimauchi T, et al., 2015). Several viruses use a similar structure 
known as a virological synapse (VS) as a bridge for transmission from DCs to T cells. For instance, 
DC-SIGN-mediated VS formation enhances HIV-1 transmission from DCs to T cells  (Felts R L, et al., 
2010). To determine whether cell-to-cell contact between DCs and T cells is necessary for JEV transfer, 
JEV-pulsed DCs were co-cultured with T cells in a non-contact system in which a semi-permeable 
transwell membrane prevented direct contact between the two types of cell but allowed free passage of 
cell-free viruses (i.e., DC/T co-cultures; Figure 2A-b). We compared the infection of JEV in the DC-T 
co-cultures with those in DCs or T cells cultured alone. Compared to that in the DC–T co-cultures, JEV 
replication was reduced in DC/T co-cultures (Figure 2B, 2C), implying a requirement of direct cell-to-
cell contact for the transfer of DC-captured JEV particles to T cells. 
 
DC-captured JEV particles are transferred to T cells via virological synapses formed at DC–T 
cell junctions 
To assess whether JEV particles were transferred from DCs to T cells via VS formed at the junction 
between the two cell types, DCs were exposed to JEV-AF488, co-cultured with CellTracker Blue-
labeled T cells, and then immediately subjected to confocal microscopy analysis. Live-cell images 
revealed that T cells moved randomly and “scanned” the surface of DCs, followed by the formation of 
junctions (Figure 3A) and viral particle transmission, as reported by others  (Arrighi J F, et al., 2004; 
Dale B M, et al., 2011). VS formation was quantified using flow cytometric analysis by determining 
the percentage of JEV-AF488+ CellTracker Blue+ DC-SIGN+ cell clusters. JEV binding-induced VS 
formation was rapid and was maintained over time. VS appeared as early as 5 min post co-cultivation, 
and most of them formed between 5 and 15 min (Supplementary Material S3). Viral particles typically 
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moved to the VS between DCs and T cells and were then directionally transferred to T cells (Figure 3B 
and Supplementary Material S4–S5). 
 
DISCUSSION 
The antigen-presenting and migratory capabilities of DCs are exploited by viruses such as HIV-1 to 
invade immune surveillance and gain access to cells that are more permissive for viral 
replication (Geijtenbeek T B, et al., 2000; Norcross M A, 1984). Although DC-SIGN has been shown 
to bind many viruses, its role in mediating trans-infection of T cells has only been described for HIV-
1, cytomegalovirus, enterovirus, and measles virus (de Witte L, et al., 2008; Geijtenbeek T B, et al., 
2000; Halary F, et al., 2002; Ren X X, et al., 2014). The findings presented here expand these 
observations to a flavivirus: DC-SIGN facilitated JEV transmission from DCs to T cells in trans, and 
DC-captured JEV particles were transferred to T lymphocytes via VS formed at DC–T cell junctions. 
Studies on HIV-1 have shown that DC-SIGN promotes the formation of VS between HIV-1-
pulsed DCs and CD4+ T cells, allowing HIV-1 to escape immune surveillance before dissemination to 
CD4+ T cells. DC-SIGN-bound HIV-1 particles are stable and retain their infectivity for days, which is 
important for long-term HIV-1 transmission. Our live-cell imaging study revealed that VS formation 
was initiated by normal cellular interactions in which T cells randomly “scanned” DCs until a stable 
DC–T cell junction was formed. JEV particles captured by DCs were concentrated at the VS before 
their transfer. The VS formed rapidly within a few minutes after the incubation of JEV-pulsed DCs with 
T cells and then underwent dissociation, and most viral particles were internalized into DCs within 15 
min. An open question is whether viral internalization is a prerequisite for JEV transmission from DCs 
to T cells in trans. 
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Further to our initial observations that DC-SIGN efficiently captures and concentrates viral 
particles at the cell surface to facilitate the cis infection of JEV (Wang P, et al., 2016), the results of the 
current study indicate that JEV is also transferred from DCs to T cells via VS formed at DC–T cell 
junctions. This suggests that DC-SIGN is a potential therapeutic target for treatment of JEV infection. 
It will be important to determine in future studies whether DC-SIGN-mediated JEV transmission occurs 
in vivo, establish the degree to which this is responsible for the ability of DCs to potentiate T cell 
infection, and evaluate how this affects JEV pathogenesis. JEV can replicate in various types of primary 
cells and immortalized cell lines from a wide variety of avian, mammalian, amphibian and insect 
species, suggesting that multiple receptors are likely to be involved in JEV infection  (Pierson T C, et 
al., 2013). In our study, mAb161 resulted in partial inhibition. Although we used relatively high dose 
of mAb161, the inhibitory effect did not improve, suggesting that other potential molecules likely also 
contribute to JEV binding/entry. Given that JEV did not bind efficiently to T cells in the absence of 
DCs, we speculate that JEV binding to DC-SIGN induces a conformational change that promotes a 
closer interaction between E protein and T cells. Alternatively, the binding of JEV particles to DC-
SIGN may concentrate virions at the surface of DCs and thus increase the probability that other cells in 
contact with DCs become infected. 
 
ACKNOWLEDGMENTS 
This work was supported by the National Key Research and Development Program of China 
(2016YFC1200400), the National Natural Science Foundation of China Grants (81572009 and 
31570165) and the National High Technology Research and Development Program of China 
(2014AA021406). We thank the Core Facility and Technical Support at Wuhan Institute of 
14 
Virology for technique supports of Confocal Microscopy (Dr. Ding Gao) and Flow Cytometry 
(Ms. Juan Min). 
 
COMPLIANCE WITH ETHICS GUIDELINES 
The authors declare that they have no competing interests. All protocols involving human blood 
samples were reviewed and approved by the Local Research Ethics Committee. Informed 
written consents from the human subjects were obtained in this study. 
 
AUTHOR CONTRIBUTIONS 
PW performed the major experiments and statistical analysis, drafted and revised the 
manuscript. ML, WL and DZ participated in the statistical analysis and revised the manuscript. 
QXH and YLL designed the study, drafted and revised the manuscript. All authors read and 




Aleyas A G, George J A, Han Y W, Rahman M M, Kim S J, Han S B, Kim B S, Kim K, Eo S K. 2009. Functional 
modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor 
molecule-dependent and -independent pathways. J Immunol, 183: 2462-2474. 
Arrighi J F, Pion M, Garcia E, Escola J M, van Kooyk Y, Geijtenbeek T B, Piguet V. 2004. DC-SIGN-mediated infectious 
synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J Exp Med, 200: 1279-
1288. 
Dale B M, McNerney G P, Thompson D L, Hubner W, de Los Reyes K, Chuang F Y, Huser T, Chen B K. 2011. Cell-to-
cell transfer of HIV-1 via virological synapses leads to endosomal virion maturation that activates viral 
membrane fusion. Cell Host Microbe, 10: 551-562. 
de Witte L, de Vries R D, van der Vlist M, Yuksel S, Litjens M, de Swart R L, Geijtenbeek T B. 2008. DC-SIGN and 
CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS 
Pathog, 4: e1000049. 
Diamond M S, Shrestha B, Mehlhop E, Sitati E, Engle M. 2003. Innate and adaptive immune responses determine 
protection against disseminated infection by West Nile encephalitis virus. Viral Immunol, 16: 259-278. 
Felts R L, Narayan K, Estes J D, Shi D, Trubey C M, Fu J, Hartnell L M, Ruthel G T, Schneider D K, Nagashima K, Bess 
J W, Jr., Bavari S, Lowekamp B C, Bliss D, Lifson J D, Subramaniam S. 2010. 3D visualization of HIV transfer 
at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A, 107: 13336-13341. 
Figdor C G, van Kooyk Y, Adema G J. 2002. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev 
Immunol, 2: 77-84. 
Geijtenbeek T B, Torensma R, van Vliet S J, van Duijnhoven G C, Adema G J, van Kooyk Y, Figdor C G. 2000. 
Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune 
responses. Cell, 100: 575-585. 
Geijtenbeek T B, Kwon D S, Torensma R, van Vliet S J, van Duijnhoven G C, Middel J, Cornelissen I L, Nottet H S, 
KewalRamani V N, Littman D R, Figdor C G, van Kooyk Y. 2000. DC-SIGN, a dendritic cell-specific HIV-1-
binding protein that enhances trans-infection of T cells. Cell, 100: 587-597. 
Halary F, Amara A, Lortat-Jacob H, Messerle M, Delaunay T, Houles C, Fieschi F, Arenzana-Seisdedos F, Moreau J 
F, Dechanet-Merville J. 2002. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell 
infection and target cell trans-infection. Immunity, 17: 653-664. 
Iwasaki Y, Zhao J X, Yamamoto T, Konno H. 1986. Immunohistochemical demonstration of viral antigens in 
Japanese encephalitis. Acta Neuropathol, 70: 79-81. 
Jin W, Li C, Du T, Hu K, Huang X, Hu Q. 2014. DC-SIGN plays a stronger role than DCIR in mediating HIV-1 capture 
and transfer. Virology, 458-459: 83-92. 
Li C, Jin W, Du T, Wu B, Liu Y, Shattock R J, Hu Q. 2014. Binding of HIV-1 virions to alpha4beta 7 expressing cells 
and impact of antagonizing alpha4beta 7 on HIV-1 infection of primary CD4+ T cells. Virol Sin, 29: 381-
392. 
Malissen B, Tamoutounour S, Henri S. 2014. The origins and functions of dendritic cells and macrophages in the 
skin. Nat Rev Immunol, 14: 417-428. 
Mathur A, Kulshreshtha R, Chaturvedi U C. 1989. Evidence for latency of Japanese encephalitis virus in T 
lymphocytes. J Gen Virol, 70 ( Pt 2): 461-465. 
Mathur A, Arora K L, Rawat S, Chaturvedi U C. 1986. Persistence, latency and reactivation of Japanese 
encephalitis virus infection in mice. J Gen Virol, 67 ( Pt 2): 381-385. 
Norcross M A. 1984. A synaptic basis for T-lymphocyte activation. Ann Immunol (Paris), 135D: 113-134. 
16 
Paul W E, Brown M, Hornbeck P, Mizuguchi J, Ohara J, Rabin E, Snapper C, Tsang W. 1987. Regulation of B-
lymphocyte activation, proliferation, and differentiation. Ann N Y Acad Sci, 505: 82-89. 
Pierson T C, Kielian M. 2013. Flaviviruses: braking the entering. Curr Opin Virol, 3: 3-12. 
Ren X X, Ma L, Liu Q W, Li C, Huang Z, Wu L, Xiong S D, Wang J H, Wang H B. 2014. The molecule of DC-SIGN 
captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection. Virol J, 11: 47. 
Sharma S, Mathur A, Prakash V, Kulshreshtha R, Kumar R, Chaturvedi U C. 1991. Japanese encephalitis virus 
latency in peripheral blood lymphocytes and recurrence of infection in children. Clin Exp Immunol, 85: 
85-89. 
Shimauchi T, Piguet V. 2015. DC-T cell virological synapses and the skin: novel perspectives in dermatology. Exp 
Dermatol, 24: 1-4. 
van den Hurk A F, Ritchie S A, Mackenzie J S. 2009. Ecology and geographical expansion of Japanese encephalitis 
virus. Annu Rev Entomol, 54: 17-35. 
Wang P, Hu K, Luo S, Zhang M, Deng X, Li C, Jin W, Hu B, He S, Li M, Du T, Xiao G, Zhang B, Liu Y, Hu Q. 2016. DC-
SIGN as an attachment factor mediates Japanese encephalitis virus infection of human dendritic cells 
via interaction with a single high-mannose residue of viral E glycoprotein. Virology, 488: 108-119. 
  
17 
Titles and legends to figures 
 
Figure 1. DC-captured JEV is transferred to T cells. (A) Transmission of cell-free (in cis) and DC-
associated (in trans) JEV-AF488 to T cells. DCs were pulsed with JEV-AF488 (MOI = 10) on ice for 
1 h and washed extensively to remove unbound viruses. T cells were labeled with CellTracker Blue 
fluorescent dye before pulsing with JEV-AF488 (cell-free virus, MOI = 10) or DC-associated JEV-
AF488 for 30 min. JEV transmission was quantified by analyzing the CellTracker Blue+ JEV-AF488+ 
population. Results of a representative experiment (n = 3) are shown. (B) Transmission of JEV-AF488 
in cis and in trans was assessed by measuring mean fluorescence intensity (MFI). Data represent mean 
± SD of three independent experiments. (C) Transmission of JEV-AF488 in trans in the presence of C-
type lectin inhibitors. DCs pulsed with JEV-AF488 were incubated with CellTracker Blue-labeled T 
cells in the presence of inhibitors for 30 min, fixed, and analyzed by FACS. T cells were first gated 
according to forward and side scatter characteristics, followed by analysis of CellTracker Blue+ JEV-
AF488+ cells. Results of a representative experiment (n = 3) are shown. (D) Transmission of JEV-
AF488 to T cells in trans in the presence of inhibitors was assessed by measuring MFI. Data represent 
mean ± SD of three independent experiments.
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Figure 2. DC-SIGN is required for efficient JEV infection in DC–T co-cultures. DCs were infected 
with JEV at a low titer (MOI = 0.001) in the absence or presence of C-type lectin inhibitors and then 
co-cultured in contact (DC–T) or without contact (DC/T) with T cells for 72 h. JEV-infected DCs or T 
cells without co-culturing served as controls. (A-a) Model of DC–T. (A-b) Model of DC/T. (B) 
Intracellular viral proteins were detected by western blotting. (C) The progeny virus particles of the 




Figure 3. Live cell images of JEV particles transmitted from DCs to T cells. CellTracker Blue-labeled 
T cells were added to DCs (pulsed with JEV-AF488 on ice for 1 h) before analysis by live-cell confocal 
microscopy at 37 °C. (A) The processes of JEV transmission from DCs to T cells were: T cells “scanned” 
DCs followed by the formation of junctions. (B) Transfer of viral particles from DCs to T cells. Arrows 
indicate typical viral particles. Scale bars, 3.3 μm (A) and 2.9 μm (B). Results of a representative 
experiment (n = 3) are shown. 
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